Marshall Wace’s Yarrow Bioscience YARW Stock Holding History

Marshall Wace’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-183	Closed	-$169K	–	4080
2021 Q4	$169K	Buy	+183	New	+$196K	﹤0.01%	3222
2021 Q2	–	Sell	-72	Closed	-$442K	–	3133
2021 Q1	$442K	Buy	+72	New	+$522K	﹤0.01%	1993

Other funds holding YARW

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Marshall Wace's YARW Position: Q1 2022 in Review

Marshall Wace sold out of Yarrow Bioscience (YARW) in Q1 2022, closing a stake of 183 shares — an estimated $169K sold.

Marshall Wace first reported a position in YARW in Q1 2021 and held it in 2 quarters. The position peaked at $442K in Q1 2021. 41 funds tracked by Wall St. Rank hold YARW as of Q1 2022.

Marshall Wace reported no remaining Yarrow Bioscience position as of Q1 2022 after selling out during the quarter.
Marshall Wace sold 183 Yarrow Bioscience shares in Q1 2022, an estimated $169K.
Marshall Wace first reported a position in Yarrow Bioscience in Q1 2021 and held it in 2 quarters.
Marshall Wace's Yarrow Bioscience position peaked at $442K in Q1 2021.
41 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.